2005 | p value | ||
---|---|---|---|
Spacer use | 17% (13–22) | 26% (21–31) | 0.015 |
Ipratropium use | 58% (51–64) | 44% (38–50) | 0.0029 |
Corticosteroid use | 75% (69–81) | 70% (64–75) | 0.1429 |
Admitted | 55% (48 – 61) | 37% (31–43) | < 0.0001 |
CXR done | 48% (42–55) | 31% (26–37) | 0.0001 |
ED action plan | 11% (7–15) | 23% (18–28) | 0.0003 |